Stimulation of feeding in lean but not in obese Zucker rats by a selective neuropeptide Y Y5 receptor agonist.
Obese Zucker rats are characterized by a reduced hypothalamic NPY receptor density. We tested the effects of intracerebroventricular injections of human NPY (hNPY) and [D-Trp32]NPY, a weak but selective NPY Y5 receptor agonist, on food intake in lean and obese Zucker rats. The effect of a maximal dose of hNPY (10 microg) on feeding was more pronounced in lean than in obese rats. [D-Trp32]NPY (10 microg) stimulated feeding in lean but not in obese Zucker rats. It did not affect the feeding response to hNPY, excluding the activation of an inhibitory receptor. These results are in favor of a down-regulation of the NPY 'feeding' receptor in the obese rat, which is suggested to be the Y5 subtype.
Wyss
P
P
Obesity Pharmacology, Metabolic and Cardiovascular Disease, Novartis Pharma AG, Basle, Switzerland.
Levens
N
N
Stricker-Krongrad
A
A
D000818:Animals; D015536:Down-Regulation / Q000187:drug effects; D004435:Eating / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D009478:Neuropeptide Y / Q000008:administration & dosage / Q000494:pharmacology; D009765:Obesity / Q000235:genetics / Q000523:psychology*; D051381:Rats; D011924:Rats, Zucker; D017476:Receptors, Neuropeptide Y / Q000819:agonists*
D009478:Neuropeptide Y; D017476:Receptors, Neuropeptide Y; C100568:neuropeptide Y5 receptor